evolve health

What evolve health does

Evolve Health is an outpatient interventional psychiatry clinic operating three locations in Oregon (Beaverton, Portland, and Bend), founded in 2019. The clinic delivers three core treatment modalities for patients with treatment-resistant depression and related mental health conditions: Spravato (esketamine nasal spray, FDA-approved for treatment-resistant depression and major depressive disorder with suicidal ideation), IV Ketamine infusion therapy (off-label use covering treatment-resistant depression, PTSD, OCD, anxiety, bipolar depression, postpartum depression, and migraines), and Transcranial Magnetic Stimulation (TMS, a non-invasive electromagnetic procedure delivered over up to 36 sessions). According to company materials, Evolve Health has administered more than 25,000 patient treatments using its internal monitoring protocol.

The business operates a referral-based B2B2C go-to-market model: patients must obtain referrals from primary care physicians, psychiatrists, or other mental health providers before evaluation by Evolve Health's psychiatric providers. Revenue mechanics are mixed — Spravato and TMS are typically covered by insurance (with the clinic providing preauthorization support), while IV Ketamine is predominantly self-pay. Treatment courses span weeks to months, with maintenance protocols extending patient relationships over 12–18 months on average. The clinic maintains extended hours (e.g., Beaverton operates until 8:30pm weekdays), expanded office capacity across three sites, and a marketing presence across website, blog, Instagram, Facebook, and YouTube.

Evolve Health is privately held with no disclosed institutional funding, parent company, M&A activity, or partnerships. Its competitive positioning centers on clinical experience depth (claimed to be "one of the most experienced Spravato treatment centers in the country"), senior clinical talent (e.g., a Director of TMS with 33 years of nursing experience), and a calming, non-judgmental care environment. Reported clinical outcomes include up to 75% remission rates for TMS and rapid symptom relief for ketamine-based therapies. The company does not disclose revenue, headcount beyond the 11–50 band, or financial metrics.

Name

evolve health

Legal name

Evolve Health

Website

https://evolvehealthcares.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Outpatient interventional psychiatry clinic in Oregon operating three locations (Beaverton, Portland, Bend) that delivers Spravato, IV Ketamine, and TMS treatments to patients with treatment-resistant depression and related mental health conditions through a referral-based, insurance-accepted model.

Ownership category

akta.pro rank

Product category

Outpatient Mental Health Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Outpatient Mental Health Clinics & Counseling Centers (HLAFACAA)

akta.pro secondary industry

Outpatient Mental Health & Counseling Clinics (HLAFABAC)

Keywords

• Interventional psychiatry
• Ketamine infusion therapy
• Transcranial magnetic stimulation
• Treatment-resistant depression
• Outpatient mental health

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Spravato Treatment Services: Revenue from administering FDA-approved Spravato (esketamine) nasal spray treatments for treatment-resistant depression. Covered by most insurance companies with preauthorization.
2. IV Ketamine Therapy: Revenue from IV ketamine infusion treatments. Currently not covered by insurance, patients pay out of pocket. Treatment series of 4-6 infusions followed by maintenance infusions.
3. TMS Therapy: Revenue from Transcranial Magnetic Stimulation treatments. Covered by most insurance providers. Treatment series of up to 36 sessions.
4. Patient Consultation Services: Initial psychiatric evaluations and ongoing consultations to develop and monitor treatment plans. Works with referring providers to determine treatment appropriateness.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels8 records

Core offering

Evolve Health operates outpatient mental health clinics that deliver interventional psychiatry treatments — specifically Spravato (esketamine) nasal spray, IV Ketamine infusion therapy, and Transcranial Magnetic Stimulation (TMS) — for adults with treatment-resistant depression and related conditions such as PTSD, OCD, anxiety, bipolar disorder, postpartum depression, and migraines. Treatments are administered on-site at three Oregon clinic locations under medical supervision with continuous monitoring, and patients typically access services through provider referrals and insurance preauthorization.

Product overview

Evolve Health is an outpatient mental health clinic offering three core interventional psychiatry treatment services: Spravato (esketamine) nasal spray, IV Ketamine infusion therapy, and TMS (Transcranial Magnetic Stimulation). These treatments target treatment-resistant depression and other mental health conditions. Spravato and IV Ketamine work through glutamate system modulation, while TMS uses electromagnetic stimulation of specific brain regions. All treatments are administered in clinical settings with medical supervision.

Differentiator

Problem solved

Functional benefit

Products and services

• Spravato (esketamine) treatment FDA-approved esketamine nasal spray administered under medical supervision for adults with treatment-resistant depression and major depressive disorder with suicidal ideation, with a two-hour monitoring period after each dose. Covered by most insurance plans with preauthorization assistance from Evolve Health's insurance coordinators.
• IV Ketamine infusion therapy Intravenous ketamine infusions at subanesthetic doses for treatment-resistant depression, bipolar depression, PTSD, OCD, anxiety, postpartum depression, and migraines, delivered in private suites with calming environments (dim lights, private flat screens with relaxing sounds and visuals). Self-pay only (not covered by insurance); typical protocol is 4–6 infusions over two weeks followed by maintenance infusions 1–3 months apart.
• TMS (Transcranial Magnetic Stimulation) Non-invasive, FDA-cleared brain stimulation procedure using magnetic fields to stimulate nerve cells in the brain for treatment of depression. Treatment series of up to 36 sessions using a 19-minute depression protocol administered once daily, five days a week for six weeks (30 sessions), followed by tapering over two to three weeks. Covered by most insurance providers with preauthorization; does not affect memory or cognitive function.

Quantifiable outcome

• Over 25,000 patient treatments administered safely
• +4 more outcomes

Named customers11 records

Segments8 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Expansion highlights5 records

Direct peers

• Greenbrook TMS NeuroHealth: Multi-site TMS-focused treatment network offering transcranial magnetic stimulation for depression and OCD. Comparable to Evolve Health as a TMS service provider targeting treatment-resistant patients in outpatient clinic settings.
• Mindbloom: At-home ketamine therapy provider for depression, anxiety, and PTSD. Comparable to Evolve Health as a ketamine-based interventional psychiatry service targeting treatment-resistant mental health conditions, though delivered in a different (at-home) setting.
• NueLife: Ketamine infusion therapy provider with outpatient clinics treating depression, PTSD, and anxiety. Directly comparable to Evolve Health's IV Ketamine offering as a regional interventional psychiatry clinic.
• Innerwell: Psychedelic-assisted therapy practice offering ketamine treatment for depression and anxiety. Comparable to Evolve Health as an interventional psychiatry operator targeting treatment-resistant mental health patients.
• Apollo TMS: TMS therapy clinic network offering transcranial magnetic stimulation for depression and other mood disorders. Comparable to Evolve Health as a specialty outpatient TMS provider.
• Klarity Clinic: Outpatient mental health provider offering ketamine therapy and interventional psychiatry treatments. Comparable to Evolve Health in treatment modality mix and patient target (treatment-resistant depression).

Broad incumbents

• Talkiatry: Large telepsychiatry platform offering psychiatric evaluation and medication management. Adjacent rather than directly competitive, but represents the broader psychiatry care delivery space in which Evolve Health's specialty services sit.
• Cerebral: Large online mental health platform providing medication management and therapy for anxiety and depression. Comparable as a broader mental health care delivery model, though Cerebral operates at much larger scale and does not specialize in interventional psychiatry.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@evolvehealthcares
• Facebookfacebook.com/evolvehealthcares
• Instagraminstagram.com/evolvehealthcares
• LinkedInlinkedin.com/company/evolvehealthcares

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about evolve health